US$ 26.33
glp 1 agonist Classification of currently available glucagon-like peptide-1 receptor GLP-1 Receptor Agonists as Treatments
Description
They are approved for adults and pediatric patients aged 10 years and older

Remember, GLP-1 RAs were designed to treat type 2 diabetes

J Med Assoc Thail Chotmaihet Thangphaet (2010) 93 Suppl 7:S166170

Mazdutide's potential advantages lie in its glucagon component, which directly targets hepatic steatosis and may prove particularly valuable for patients with MASH or metabolic liver disease

HY: Writing review & editing, Funding acquisition, Formal analysis, Data curation

(ISBN: 978-1-4052-3648-8)
